Table 1 Details of studies comparing short antibiotic treatment with conventional treatment (7–10 days) in patients with acute exacerbations of chronic bronchitis and COPD
ReferenceYear of publicationQuality scoreConcealmentStudy sizeMean age of subjectsOutpatients or inpatientsTreatmentDuration(days)Early follow-up(days)Late follow-up(days)
Langan4519984Unknown68455.9OutpatientsCefuroxime58–1028–35
57.1Claritromycin7
Lorenz4619984Unknown22256.0UnknownCefixime510–1327–33
54.0Cefixime10
Langan2119994Unknown54456.8OutpatientsGrepafloxacin511–1331–38
56.3Grepafloxacin10
Wasilewski (a)2219995Adequate49952.0OutpatientsDirithromycin510–1217–21
52.0Erythromycin7
Wasilewski (b)2219995Adequate55852.0OutpatientsDirithromycin510–1217–21
52.0Erythromycin7
Wilson4719994Unknown75060.0BothMoxifloxacin51428–35
60.2Claritromycin7
Chodosh1920005Adequate61456.9OutpatientsMoxifloxacin510–1617–27
56.2Moxifloxacin10
File4820004Unknown60064.2OutpatientsGemifloxacin514–2128–35
64.0Co-amoxiclav7
Fogarty2320004Unknown54854.0UnknownCefdinir517–2128–42
57.0Cefprozil10
Paster2620005Adequate58654.0OutpatientsCefdinir512–1926–40
52.0Loracerbef7
Gotfried2020012Unknown34948.0OutpatientsGatifloxacin514–2128–35
49.0Gatifloxacin7
Masterton4920013Unknown53260.7OutpatientsLevofloxacin514–1735–42
59.5Levofloxacin7
Aubier5020024Unknown32561.5OutpatientsTelithromycin517–2131–36
66.0Co-clavulanate10
Wilson2520023Unknown71258.7InpatientsGemifloxacin514–2128–35
58.4Claritromycin7
Soler5120033Unknown28260.1BothGatifloxacin511–1431–38
61.9Co-clavulanate10
Zervos5220035Adequate37650.5UnknownTelithromycin517–2431–45
57.0Cefuroxime10
Sethi5320045Adequate36061.6UnknownGemifloxacin514–2128–35
63.4Levofloxacin7
Fogarty5420053Unknown65059.5OutpatientsTelithromycin517–2431–36
59.4Clarithromycin10
Gotfried2420054Unknown48562.1OutpatientsClarithromycin517–2137–40
61.6Clarithromycin7
Sethi5520054Unknown89360.1BothCo-amoxiclav 2000/125514–2128–35
60.3Co-amoxiclav 875/1257
Alvarez-Sala2720063Unknown54161.1UnknownCefditoren pivoxil510–1225–35
61.0Cefuroxime10